
Hobbies and interests
Science
Cooking
Baking
Gardening
Volleyball
Driti Rajkumar
1x
Finalist1x
Winner
Driti Rajkumar
1x
Finalist1x
WinnerEducation
Portola High
High SchoolMiscellaneous
Desired degree level:
Doctoral degree program (PhD, MD, JD, etc.)
Majors of interest:
- Biochemistry, Biophysics and Molecular Biology
- Microbiological Sciences and Immunology
- Biology/Biotechnology Technologies/Technicians
Career
Dream career field:
Research
Dream career goals:
Bio-Rad Irvine/Santa Ana Scholarship
WinnerMy passion for science began not in a lab, but on a playground I climbed alone. When I was a child, my father was unable to join my brother and me on the jungle gym; a deer tick had sapped his strength. At the time, I didn’t understand why he stayed inside, but years later, learning about the molecular mechanics of Lyme disease transformed that childhood confusion into a drive for discovery. This personal history is why my first hero in science is Dr. Katalin Karikó, a woman whose tenacity fundamentally reshaped modern medicine.
Dr. Karikó is now globally celebrated for her Nobel Prize-winning work on nucleoside-based modifications, a breakthrough that suppressed the inflammatory response to synthetic mRNA. This discovery was the reason for the potential for mRNA vaccines, including those for COVID-19. However, I am most moved by the decades she spent in academic obscurity. I first discovered her memoir, Breaking Through: My Life in Science, while visiting the Apollo Cancer Institute in Chennai, India. I was there to coordinate a letter-writing program for pediatric patients, and finding her book felt like a providential encounter.
Reading about her childhood in rural Hungary and her struggles as an immigrant, facing demotions and a lack of funding because her ideas were deemed too radical, resonated with my own experiences in the Pearlman Lab at UC Irvine. While investigating how bacteriophages degrade biofilms to disrupt Pseudomonas aeruginosa growth, my project was nearly derailed when my PhD student mentor left the lab. Like Dr. Karikó, I realized that progress is rarely a straight line. Her story gave me the strength to see logistical hurdles not as endings, but as puzzles. Today, I am fortunate to be connected with her on LinkedIn, where her advocacy for basic research serves as a daily reminder to remain resilient in the face of academic skepticism.
This same spirit of persistence led me to my second hero, Dr. Mitchell Brin, a pioneer in the therapeutic use of botulinum toxin. During my internship at AbbVie last summer, I sought out scientists to help me unpack my stalled experiments at UCI. Meeting the man who revolutionized the treatment of movement disorders was intimidating, yet Dr. Brin’s humility was immediate.
I explained my research journey to him, how I had pivoted toward bioinformatics and computational modeling under Dr. Christopher Negron to keep my phage research alive. What struck me most wasn't just Dr. Brin's expertise, but his genuine curiosity. He wasn’t merely "taking a meeting"; he was actively engaging with my data on viral-bacterial interactions. He listened to a student intern with the same intensity he might bring to a clinical trial.
Dr. Brin and Dr. Karikó represent the two pillars of the scientist I hope to become. From Dr. Karikó, I learned that molecular insight can translate into profound human impact if one has the grit to defend their ideas. From Dr. Brin, I learned that a great researcher never loses respect for the next generation. I strive to emulate both, remaining as entranced by the "why" of science decades from now as I am today. As Dr. Brin reminds his audience, “chance prepares the prepared mind”, and I’m excited to prepare for my next few years as an undergraduate.